Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hib Diseases”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Testing effectiveness (Phase 2)Study completedNCT00158808
What this trial is testing

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

Who this might be right for
Hib DiseaseHepatitis BPertussis+2 more
GlaxoSmithKline 175
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Not applicableStudy completedNCT00661401
What this trial is testing

Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
Federal University of São Paulo 5
Large-scale testing (Phase 3)Study completedNCT00317122
What this trial is testing

Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth

Who this might be right for
Diphtheria; Haemophilus Influenzae Type b; Hepatitis B; Tetanus; Whole Cell Pertussis
GlaxoSmithKline 192
Large-scale testing (Phase 3)Study completedNCT03891758
What this trial is testing

Confirmatory Study of BK1310 in Healthy Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Tanabe Pharma Corporation 267
Testing effectiveness (Phase 2)UnknownNCT04073459
What this trial is testing

Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Testing effectiveness (Phase 2)Study completedNCT00385320
What this trial is testing

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 2,640
Large-scale testing (Phase 3)Study completedNCT00325143
What this trial is testing

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

Who this might be right for
Haemophilus Influenzae Type bDiphtheriaTetanus+2 more
GlaxoSmithKline 702
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Post-approval studies (Phase 4)Study completedNCT01491087
What this trial is testing

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi Pasteur, a Sanofi Company 900
Testing effectiveness (Phase 2)Study completedNCT00376779
What this trial is testing

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Who this might be right for
Acellular PertussisTetanusDiphtheria+3 more
GlaxoSmithKline 450
Post-approval studies (Phase 4)Study completedNCT01659996
What this trial is testing

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Who this might be right for
MeningitisMeningococcal InfectionDiphtheria+3 more
Sanofi Pasteur, a Sanofi Company 1,394
Large-scale testing (Phase 3)Study completedNCT01362517
What this trial is testing

Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 131
Large-scale testing (Phase 3)Study completedNCT00291343
What this trial is testing

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 296
Post-approval studies (Phase 4)Study completedNCT04535037
What this trial is testing

Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Who this might be right for
Diphtheria
GlaxoSmithKline 500
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Large-scale testing (Phase 3)Study completedNCT00831753
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 263
Next Page